Physician profile
Ryan Ravi Ramsook
NPI 1679983738
$20,525.69
in general payments reported to CMS, 2019-2025
25 companies · $3,508 in 2025
The $3,508 reported for 2025 was more than what 96% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,794 · 2020: $1,528 · 2021: $2,722 · 2022: $3,786 · 2023: $2,158 · 2024: $4,031 · 2025: $3,508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,210 · Travel and Lodging: $3,486.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,210.21 |
| Travel and Lodging | $3,486.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,187.33 | 2019-2025 | Proclaim, Eterna, Axium |
| Medtronic, INC. | $6,555.03 | 2022-2025 | Kyphon Express II Kyphopak Tray, Synchromedii, Intellis Adaptivestim |
| Boston Scientific Corporation | $2,173.01 | 2019-2024 | |
| Vertos Medical, INC. | $791.07 | 2021-2022 | |
| Si-Bone, INC. | $686.71 | 2024-2025 | |
| Surgentec | $487.91 | 2023 | Ion Facet Screw System, Tilink |
| Painteq LLC | $308.83 | 2022-2023 | Painteq |
| Spr Therapeutics, INC | $246.58 | 2020-2025 | Sprint Pns System |
| Medtronic USA, INC. | $222.11 | 2019-2020 | |
| Vertiflex, INC. | $118.33 | 2019 | |
| Siemens Medical Solutions USA, INC. | $115.57 | 2020 | |
| Avanos Medical | $105.25 | 2020-2023 | Generator |
| Nalu Medical, INC. | $102.92 | 2021-2025 | Nalu Neurostimulation System |
| Relievant Medsystems, INC. | $99.92 | 2019-2022 | |
| Saluda Medical Americas, INC. | $98.51 | 2022-2025 | Evoke |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $82.76 | 2020-2021 | |
| Biotronik Nro, INC. | $21.80 | 2025 | Prospera |
| Allergan, INC. | $20.36 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.26 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.08 | 2025 | Iovera, Zilretta |
| Daiichi Sankyo INC. | $16.45 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.48 | 2019 | |
| Lilly USA, LLC | $12.54 | 2019 | |
| Scilex Pharmaceuticals INC. | $11.95 | 2022 | |
| Biodelivery Sciences International, INC. | $10.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Ramsook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.